Abstract:Shanshan Cui, 1 Xiaobo Feng, 2 Zhongyuan Xia 1 1 Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, People's Republic of China; 2 Department of Anesthesiology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei Province, People's Republic of China Correspondence: Zhongyuan Xia, Department of Anesthesiology, Renmin Hospital of Wuhan University, Ziyang Road, Wuchang District, Wuhan, Hubei Province, People's Republic of China, Email Background: In traditional Chinese medicine, Ligusticum chuanxiong Hort . (LCH) is used to treat neuropathic pain (NP). This study was performed to investigate the underlying pharmacological mechanisms. Methods: The main components of the LCH were obtained from the TCMSP database. The targets of the active components were obtained using the Swiss Target Prediction database and HERB database. The NP-related genes were obtained from the CTD database and GeneCard database. Protein-protein interaction (PPI) network was constructed using the STRING platform and Cytoscape 3.9.0 software. GO and KEGG enrichment analyses were performed using the DAVID database. Interactions between the key components and hub target proteins were verified using molecular docking and molecular dynamics simulation. In addition, microglial cell line HMC3 was induced to polarize to the M1 phenotype using 100 ng/mL lipopolysaccharide (LPS). Quantitative real-time polymerase chain reaction (qRT-PCR), Western blot and enzyme-linked immunosorbent assays were used to detect the expression levels of M1 markers and inflammatory factors, respectively. Results: Seven LCH active components of LCH were identified, corresponding to 387 target genes. 2019 NP-related genes were obtained, and a total of 174 NP-related genes were identified as target genes that could be modulated by LCH. Beta-sitosterol, senkyunone, wallichilide, myricanone, and mandenol were considered as the key components of LCH in the treatment of NP. SRC, BCL2, AKT1, HIF1A and HSP90AA1 were identified as the hub target proteins. GO analysis showed that 328 biological processes, 61 cell components, and 85 molecular functions were likely modulated by the components of LCH, and KEGG enrichment analysis showed that 132 signaling pathways were likely modulated by the components of LCH. Beta-sitosterol, senkyunone, wallichilide, myricanone, and mandenol showed good binding activity with hub target proteins including SRC, BCL2, AKT1, and HSP90AA1. In addition, beta-sitosterol inhibited LPS-induced M1 polarization in HMC3 in vitro. Conclusion: This study provides a theoretical basis for the application of LCH in the treatment of NP through multicomponent, multitarget, and multiple pathways. Keywords: neuropathic pain, Ligusticum chuanxiong Hort ., network pharmacology, molecular docking, microglia, inflammation Neuropathic pain (NP) is a type of chronic pain caused by damage to the peripheral or central nervous system, 1 mainly manifests as spontaneous pain, hyperalgesia, dysalgesia, and secondary hyperalgesia. 2 It is estimated that 11–40% of adults suffer from chronic pain. 3 NP often leads to sleep disorders and even depression in patients, which seriously affects the quality of life of patients. 4,5 However, traditional treatments for NP are still limited to nonsteroidal anti-inflammatory drugs, antidepressants, antiepileptics, opioid analgesics and local anesthetics. 6,7 These drugs are often insufficient to relieve NP and often have many serious side effects. Therefore, there is an urgent need to explore NP therapeutic drugs with a definite efficacy and minimal side effects. Ligusticum chuanxiong Hort . (LCH), belonging to the Umbelliferae family, is a widely used medicinal and edible plant. In China, LCH is often used to treat gynecological diseases, such as dysmenorrhea, amenorrhea, dystocia and lochia, 8,9 and it is also applied to treat ischemic diseases, such as dizziness, headache and migraine. 10–12 To date, more than 263 bioactive substances have been isolated from different parts of LCH (rhizomes, fibrous roots, and aboveground parts), including volatile oils, organic acids, phenolic acids, phthalates, alkaloids, polysaccharides, ceramides, cerebrosides and terpenoids. 12 Modern pharmacological studies have shown that LCH has analgesic, anti-inflammatory, antioxidant, antitumor, anti-coagulation, anti-depression, anti-aging, anti-atherosclerosis, and improving cardiac function effects. 13–16 However, its potential function and mechanism of action in the treatment of NP remain unclear. Network pharmacology is a promising approach that uses bioinformatics and pharma -Abstract Truncated-

Polygonum Cuspidatum Alcohol Extract Exerts Analgesic Effects via the MAPK/ERK Signaling Pathway

Anti-inflammatory and Analgesic Effects of Polygonum orientale L. Extracts

Anxiolytic effects of polydatin through the blockade of neuroinflammation in a chronic pain mouse model

The Possibility of Polygonum cuspidatum against Osteoarthritis based on Network Pharmacology

Camphor Attenuates Hyperalgesia in Neuropathic Pain Models in Mice

The Analgesic Effects of (5R,6R)6-(3-Propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1] Octane on a Mouse Model of Neuropathic Pain.

Polyphenol-enriched Penthorum chinense Pursh ameliorates alcohol-related liver injury through Ras/Raf/MEK/ERK pathway: Integrating network pharmacology and experiment validation

The exploration of active components of 701 Dieda Zhentong patch and analgesic properties on chronic constriction injury rats

The analgesic effect and mechanism of the active components screening from Corydalis yanhusuo by P2X3 receptors

Tetrahydroxystilbene Glucoside Relieves The Chronic Inflammatory Pain By Inhibiting Neuronal Apoptosis, Microglia Activation, And Glun2b Overexpression In Anterior Cingulate Cortex

Polyphyllin VI screened from Chonglou by cell membrane immobilized chromatography relieves inflammatory pain by inhibiting inflammation and normalizing the expression of P2X3 purinoceptor

Predicting the Mechanism of Tiannanxing-shengjiang Drug Pair in Treating Pain Using Network Pharmacology and Molecular Docking Technology

Mechanism of moxibustion in treating chronic inflammatory visceral pain: regulation of the p38 MAPK/ELK1 signaling pathway in the spinal cord

Cyclo(L-Pro-L-Trp) from Chilobrachys jingzhao alleviates formalin-induced inflammatory pain by suppressing the inflammatory response and inhibiting TRAF6-mediated MAPK and NF-κB signaling pathways

Natural Products with Analgesic Effect from Herbs and Nutraceuticals Used in Traditional Chinese Medicines

Polygonum cuspidatum Extract Exerts Antihyperlipidemic Effects by Regulation of PI3K/AKT/FOXO3 Signaling Pathway

TRPA1 Ion Channel Mediates the Analgesic Effects of Acupuncture at the ST36 Acupoint in Mice Suffering from Arthritis

Polygonum cuspidatum polysaccharide: A review of its extraction and purification, structure analysis, and biological activity

Study on Pharmacodynamic Material Basis and Molecular Mechanism of Wutou Tang in Pain Relief Based on Computer Simulation

Ligusticum chuanxiong Hort. Ameliorates Neuropathic Pain by Regulating Microglial M1 Polarization: A Study Based on Network Pharmacology

Analgesic Effect of Zanthoxylum nitidum Extract in Inflammatory Pain Models Through Targeting of ERK and NF-κB Signaling.